Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Change in Account Payables (2018 - 2025)

BioNexus Gene Lab's Change in Account Payables history spans 8 years, with the latest figure at -$156034.0 for Q4 2025.

  • Quarterly results put Change in Account Payables at -$156034.0 for Q4 2025, down 133.76% from a year ago — trailing twelve months through Dec 2025 was -$1.4 million (down 777.05% YoY), and the annual figure for FY2025 was -$1.4 million, down 777.05%.
  • Change in Account Payables for Q4 2025 was -$156034.0 at BioNexus Gene Lab, up from -$1.1 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $649741.0 in Q4 2022 to a low of -$1.1 million in Q3 2025.
  • The 5-year median for Change in Account Payables is -$182331.5 (2022), against an average of -$143033.4.
  • The sharpest move saw Change in Account Payables skyrocketed 2871.49% in 2024, then crashed 674.94% in 2025.
  • Year by year, Change in Account Payables stood at -$393084.0 in 2021, then soared by 265.29% to $649741.0 in 2022, then tumbled by 102.57% to -$16676.0 in 2023, then skyrocketed by 2871.49% to $462174.0 in 2024, then tumbled by 133.76% to -$156034.0 in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$156034.0, -$1.1 million, and $204963.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.